Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
Abstract Abnormal initiation and control of voluntary movements are among the principal manifestations of Parkinson’s disease (PD). However, the processes underlying these abnormalities and their potential remediation by dopamine treatment remain poorly understood. Normally, movements depend on the...
Main Authors: | Noham Wolpe, Jiaxiang Zhang, Cristina Nombela, James N. Ingram, Daniel M. Wolpert, Cam-CAN, James B. Rowe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-10-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-018-33678-3 |
Similar Items
-
Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01) -
Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan
by: Chun-Wei Chang, et al.
Published: (2019-04-01) -
Efficacy of subthalamic deep brain stimulation for levodopa-induced dyskinesia in patients with Parkinson's disease: retrospective analysis of 12 cases
by: WANG Kuan, et al.
Published: (2020-12-01) -
Pisa Syndrome in Chinese Patients With Parkinson's Disease
by: Kuncheng Liu, et al.
Published: (2019-06-01) -
IMPULSIVE-COMPULSIVE DISORDERS IN PARKINSON'S DISEASE. CLINICAL CASES
by: N. V. Fedorova, et al.
Published: (2015-10-01)